Home > Search Results: Balea Filgueiras, Jesús
  Search Tips
Advanced Search
Search collections:
Sort by: Display results: Output format:
Results overview: Found 3 records in 0.02 seconds.
Articles, 3 records found
Articles 3 records found  
1.
9 p, 748.2 KB Unmet Needs in the Management of Moderate-to-Severe Psoriasis in Spain : A Multidimensional Evaluation / Zozaya, Néboa (Universidad de Las Palmas de Gran Canaria) ; Villoro, Renata (Weber Foundation) ; Abdalla, Fernando (Weber Economía y Salud) ; Alfonso Zamora, Santiago (Psoriasis and Psoriatic Arthritis Patient and Family Association) ; Balea Filgueiras, Jesús (Complejo Hospitalario Universitario de Ferrol) ; Carrascosa, José Manuel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Delgado Sánchez, Olga (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ; Dolz Sinisterra, Francisco (Hospital Universitari Doctor Peset (València)) ; García-Ruiz, Antonio (Instituto de Investigación Biomédica de Málaga) ; Herranz Pinto, Pedro (Hospital Universitario La Paz (Madrid)) ; Manfredi, Antonio (Psoriasis and Psoriatic Arthritis Patient and Family Association) ; Martínez Olmos, José (Escuela Andaluza de Salud Pública) ; Morales de los Ríos, Paloma (Hospital General Universitario Gregorio Marañón) ; Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Ros Abarca, Sandra (Institut d'Investigació Biomèdica Sant Pau) ; Hidalgo, Álvaro (Universidad de Castilla-La Mancha) ; Universitat Autònoma de Barcelona
Psoriasis is a chronic, systemic inflammatory disease that affects the skin, with a high impact on patients' quality of life. The aim of this study was to identify and determine the relative importance of unmet needs in the management of moderate-to-severe psoriasis in Spain, from a multi-stakeholder perspective. [...]
2022 - 10.2340/actadv.v102.583
Acta dermato-venereologica, Vol. 102 (2022) , p. adv00678  
Detailed record - Creative Commons
2.
15 p, 3.0 MB Assessing the value contribution of bimekizumab for the treatment of moderate-to-severe psoriasis using a multidisciplinary reflective multi-criteria decision analysis / Zozaya, Néboa (Universidad de Las Palmas de Gran Canaria) ; Abdalla, Fernando (Weber (Madrid)) ; Alfonso Zamora, Santiago (Psoriasis and Psoriatic Arthritis Patient and Family Association) ; Balea Filgueiras, Jesus (Complejo Hospitalario Universitario de Ferrol) ; Carrascosa, José Manuel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Delgado Sánchez, Olga (Hospital Universitari Son Espases)) ; Dolz Sinisterra, Francisco (Hospital Universitari Doctor Peset (València)) ; García-Ruiz, Antonio (Instituto de Investigación Biomédica de Málaga) ; Herranz Pinto, Pedro (Hospital Universitario La Paz (Madrid)) ; Manfredi, Antonio (Psoriasis and Psoriatic Arthritis Patient and Family Association) ; Martínez Olmos, José (Escuela Andaluza de Salud Pública (Granada, Andalusia)) ; Morales de Los Ríos Luna, Paloma (Hospital General Universitario Gregorio Marañón) ; Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Ros Abarca, Sandra (Institut d'Investigació Biomèdica Sant Pau) ; Hidalgo-Vega, Álvaro (Universidad de Castilla-La Mancha) ; Universitat Autònoma de Barcelona
Background: Multi-criteria decision analysis (MCDA) was proposed to surmount arbitrary clinical decisions in the field of biological therapies for psoriatic patients. At the same time, MCDA may further highlight the potential of bimekizumab for the treatment of moderate-to-severe psoriasis, compared to placebo, adalimumab, ustekinumab, secukinumab, and even ixekizumab and risankizumab. [...]
2022 - 10.1080/14737167.2022.2063842
Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 22 Núm. 6 (2022) , p. 941-953  
Detailed record - Creative Commons
3.
9 p, 823.5 KB The social value of a PASI 90 or PASI 100 response in patients with moderate-to-severe plaque psoriasis in Spain / Maravilla-Herrera, Paulina (Weber) ; Merino, María (Weber) ; Alfonso Zamora, Santiago (Acción Psoriasis) ; Balea Filgueiras, Jesús (Complejo Hospitalario Universitario de Ferrol) ; Carrascosa, José Manuel (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Delgado Sánchez, Olga (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ; Dolz Sinisterra, Francisco (Hospital Universitari Doctor Peset (València)) ; García-Ruiz, Antonio (Universidad de Málaga) ; Herranz Pinto, Pedro (Hospital Universitario La Paz (Madrid)) ; Manfredi, Antonio (Acción Psoriasis) ; Martínez Olmos, José (Escuela Andaluza de Salud Pública (EASP)) ; Morales de los Ríos Luna, Paloma (Hospital General Universitario Gregorio Marañón) ; Puig Sanz, Lluís (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Ros Abarca, Sandra (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Hidalgo, Álvaro (Fundación Weber) ; Universitat Autònoma de Barcelona
Psoriasis is a chronic disease involving the skin, which significantly impacts the quality of life. Disease severity and treatment efficacy (i. e. , response) are assessed through the Psoriasis Area and Severity Index (PASI). [...]
2023 - 10.3389/fpubh.2023.1000776
Frontiers in Public Health, Vol. 11 (january 2023)  
Detailed record - Creative Commons

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.
UAB Digital Repository of Documents :: Search :: Submit :: Personalize :: Help
Powered by Invenio v1.1.6
Maintained by ddd.bib@uab.cat  :: Metadata license:
Working with